These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31536817)

  • 1. Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysis.
    Beyar-Katz O; Bitterman R; Zuckerman T; Ofran Y; Yahav D; Paul M
    Clin Microbiol Infect; 2020 Feb; 26(2):189-198. PubMed ID: 31536817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Strippoli GF; Hodson EM; Jones CJ; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
    Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.
    Yahav D; Gafter-Gvili A; Muchtar E; Skalsky K; Kariv G; Yeshurun M; Leibovici L; Paul M
    Eur J Cancer; 2009 Dec; 45(18):3131-48. PubMed ID: 19796930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Craig JC; Strippoli GF; Webster AC
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Jones CA; Strippoli GF; Webster AC; Craig JC
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005129. PubMed ID: 17443573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.
    Wada-Shimosato Y; Tanoshima R; Hiratoko K; Takeuchi M; Tsujimoto SI; Shiba N; Ito S; Yamanaka T; Ito S
    Transpl Infect Dis; 2019 Jun; 21(3):e13061. PubMed ID: 30756465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.
    Chen K; Cheng MP; Hammond SP; Einsele H; Marty FM
    Blood Adv; 2018 Aug; 2(16):2159-2175. PubMed ID: 30154125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against herpesvirus infections in transplant recipients.
    Ljungman P
    Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
    Fillet AM
    Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
    Ruiz-Camps I; Len O; de la Cámara R; Gurguí M; Martino R; Jarque I; Barrenetxea C; Díaz de Heredia C; Batlle M; Rovira M; de la Torre J; Torres A; Aguilar M; Espigado I; Martín-Dávila P; Bou G; Borrell N; Aguado JM; Pahissa A;
    Antivir Ther; 2011; 16(7):951-7. PubMed ID: 22024510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology].
    Cornella C; Torazza MC; Strippoli GF; Segoloni G;
    G Ital Nefrol; 2007; 24 Suppl 37():S165-78. PubMed ID: 17347963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
    Kır O; Zeytinoğlu A; Arda B; Yılmaz M; Aşçı G; Töz H
    Transplant Proc; 2017 Apr; 49(3):537-540. PubMed ID: 28340829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Strippoli GF; Hodson EM; Jones C; Craig JC
    Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.
    El Haddad L; Ghantoji SS; Park AK; Batista MV; Schelfhout J; Hachem J; Lobo Y; Jiang Y; Rondon G; Champlin R; Chemaly RF
    J Med Virol; 2020 Jan; 92(1):86-95. PubMed ID: 31448830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.
    Rawal BB; Shadrou S; Abubacker F; Ghahramani N
    Int J Organ Transplant Med; 2012; 3(1):10-7. PubMed ID: 25013618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.